| COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection H Al-Samkari, RS Karp Leaf, WH Dzik, JCT Carlson, AE Fogerty, ... Blood, The Journal of the American Society of Hematology 136 (4), 489-500, 2020 | 1381 | 2020 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 185 | 2023 |
| MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia AR Pyzer, D Stroopinsky, H Rajabi, A Washington, A Tagde, M Coll, ... Blood, The Journal of the American Society of Hematology 129 (13), 1791-1801, 2017 | 150 | 2017 |
| Thrombosis, bleeding, and the observational effect of early therapeutic anticoagulation on survival in critically ill patients with COVID-19 H Al-Samkari, S Gupta, RK Leaf, W Wang, RP Rosovsky, SK Brenner, ... Annals of internal medicine 174 (5), 622-632, 2021 | 127 | 2021 |
| A meta‐analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation JI Zwicker, RK Leaf, M Carrier Journal of Thrombosis and Haemostasis 14 (9), 1736-1740, 2016 | 112 | 2016 |
| ABO phenotype and death in critically ill patients with COVID‐19 RK Leaf, H Al‐Samkari, SK Brenner, S Gupta, DE Leaf British journal of haematology 190 (4), e204, 2020 | 104 | 2020 |
| MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs AR Pyzer, D Stroopinsky, J Rosenblatt, E Anastasiadou, H Rajabi, ... Leukemia 31 (12), 2780-2790, 2017 | 68 | 2017 |
| Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors RK Leaf, C Ferreri, D Rangachari, J Mier, W Witteles, G Ansstas, ... American journal of hematology 94 (5), 563-574, 2019 | 65 | 2019 |
| Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine MR Nahas, D Stroopinsky, J Rosenblatt, L Cole, AR Pyzer, ... British journal of haematology 185 (4), 679-690, 2019 | 57 | 2019 |
| Immune checkpoint inhibitors for cancer and venous thromboembolic events J Gong, ZD Drobni, RM Alvi, SP Murphy, RJ Sullivan, SE Hartmann, ... European Journal of Cancer 158, 99-110, 2021 | 50 | 2021 |
| High prevalence of imposterism among female Harvard medical and dental students AM Holliday, G Gheihman, C Cooper, A Sullivan, H Ohyama, DE Leaf, ... Journal of general internal medicine 35, 2499-2501, 2020 | 42 | 2020 |
| Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine SRV Gadi, PAR Brunker, H Al‐Samkari, DB Sykes, RR Saff, J Lo, ... Transfusion 61 (11), 3267-3271, 2021 | 37 | 2021 |
| Kidney recovery and death in critically ill patients with COVID-19–associated acute kidney injury treated with dialysis: the STOP-COVID cohort study CM Hsu, S Gupta, H Tighiouart, N Goyal, AJ Faugno, A Tariq, ... American journal of kidney diseases 79 (3), 404-416. e1, 2022 | 36 | 2022 |
| Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease MR Nahas, RJ Soiffer, HT Kim, EP Alyea III, J Arnason, R Joyce, JH Antin, ... Blood, The Journal of the American Society of Hematology 131 (25), 2836-2845, 2018 | 36 | 2018 |
| Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC 1 M Bar‐Natan, D Stroopinsky, K Luptakova, MD Coll, A Apel, H Rajabi, ... British journal of haematology 176 (6), 929-938, 2017 | 32 | 2017 |
| Diagnosis and Management of Rare Immune‐Related Adverse Events SR Schoenfeld, ME Aronow, RK Leaf, M Dougan, KL Reynolds The Oncologist 25 (1), 6-14, 2020 | 31 | 2020 |
| The role of anticoagulants in the prevention of pregnancy complications RK Leaf, JM Connors Clinical and Applied Thrombosis/Hemostasis 23 (2), 116-123, 2017 | 27 | 2017 |
| Autoimmune hemolytic anemia in a young man with acute hepatitis E infection RK Leaf, KL O'Brien, DE Leaf, RE Drews American Journal of Hematology 92 (5), E77-E79, 2017 | 23 | 2017 |
| Immunotherapy for multiple myeloma, past, present, and future: monoclonal antibodies, vaccines, and cellular therapies R Karp Leaf, HJ Cho, D Avigan Current hematologic malignancy reports 10, 395-404, 2015 | 21 | 2015 |
| Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer L Zubiri, GE Molina, MJ Mooradian, J Cohen, SM Durbin, L Petrillo, ... Journal for ImmunoTherapy of Cancer 9 (9), 2021 | 20 | 2021 |
